NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Some stuff you may not want to hear about why your doctor chooses certain drugs

Gary Schwitzer is founder and publisher of

Drug companies clearly have a lot riding on understanding doctors’ prescribing behavior and how they assign trust to brands and to specific drugs.

A Harris Poll of physicians found that:

“…when it comes to driving trust, emotional connection, relationships with sales representatives, and perceptions of the pharmaceutical company or companies backing the product can be just as influential factors as the attributes of the product itself.”

So your doc’s feelings about the drug rep may be as important as (more important than?) how good the drug is.  A Harris exec said:

“Our research clearly demonstrates that trust is about much more than efficacy alone.”

Meantime, “Restoring Confidence in the Pharmaceutical Industry” was the title of an editorial in the Journal of the American Medical Association this week.


Follow us on Facebook, and on Twitter:

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.